Reverse T3 sits in one of the most contested territories in thyroid medicine, where functional medicine and mainstream endocrinology disagree, where patients feel unheard, and where the answer to "should I test this?" depends entirely on who you ask.

If your TSH, Free T4, and Free T3 are all within range and you still feel off, some practitioners will investigate Reverse T3 as a possible explanation. Others consider it clinically irrelevant in that scenario. Both sides have reasons worth understanding.

This article presents both perspectives honestly. It covers what Reverse T3 is, the physiology behind it, when testing may add value, and when it probably won't.

A note before we get into it

A quick refresher on how thyroid hormones work

To understand Reverse T3, you need the basic thyroid pathway. For the full deep-dive, see the thyroid article.

Your thyroid gland produces primarily T4 (thyroxine), the storage form of thyroid hormone. T4 is relatively inactive. It circulates in the blood and is converted to T3 (triiodothyronine) in your tissues by enzymes called deiodinases. T3 is the active form. It enters cells, binds to nuclear receptors, and drives metabolic rate, energy production, temperature regulation, and hundreds of other cellular processes.

The standard thyroid panel measures TSH (the pituitary's signal to the thyroid; high TSH means the thyroid is underperforming), Free T4 (circulating storage hormone), and Free T3 (circulating active hormone).

Most of thyroid management is built around this pathway: TSH tells you whether the brain is asking for more hormone, Free T4 tells you whether the thyroid is delivering, Free T3 tells you whether conversion is happening. That model works well for most patients. But not for everyone.

What Reverse T3 is, and why your body makes it

When T4 is converted, it doesn't only become T3. It can also be converted to Reverse T3 (rT3), a structurally similar molecule that is biologically inactive. Reverse T3 binds to the same cellular receptors as T3 but doesn't activate them. It occupies the receptor without producing the metabolic response, functioning as a competitive inhibitor of T3 action.

Your body makes Reverse T3 deliberately. It's not a malfunction. It's a regulatory mechanism. Under normal conditions, about 40% of T4 is converted to T3 and about 40% to rT3, with the balance finely tuned by the deiodinase enzymes.

Why would the body want to brake its own metabolism? Because sometimes slowing down is adaptive. During severe illness, after major surgery, during starvation, in severe physiological stress, the body needs to conserve energy. Increasing rT3 production (and decreasing T3 production) is one of the mechanisms for achieving this. It's a metabolic dimmer switch, reducing cellular metabolic activity when the body perceives that conservation is more important than expenditure.

This is the physiology. It's well-established and uncontroversial. The controversy begins when we ask: does elevated rT3 matter clinically in otherwise "well" people who don't have acute illness or severe caloric restriction?

The functional medicine perspective

Functional medicine practitioners generally view Reverse T3 as a clinically meaningful marker in a broader set of circumstances than mainstream endocrinology recognises.

The argument: Chronic stress, chronic inflammation, chronic caloric restriction (including prolonged dieting or very low-carb diets), gut dysfunction, liver dysfunction, and chronic illness can all shift the T4 conversion balance toward rT3 and away from T3. This creates a state where TSH and T4 look normal (the brain thinks everything is fine) but at the cellular level, less active T3 is reaching the receptors because rT3 is blocking access.

The clinical presentation: Patients with normal TSH, normal T4, and even normal Free T3 on blood tests who still present with hypothyroid-like symptoms: fatigue, brain fog, cold sensitivity, weight gain, low mood, poor concentration. The functional medicine framing is that these patients have a "T3 resistance" or "poor T3 utilisation" pattern that standard thyroid panels don't capture.

The recommended testing: Reverse T3 alongside Free T3, with the T3/rT3 ratio calculated as a measure of how much active T3 is available relative to the competing inactive form.

The recommended treatment: Address the underlying driver (stress, inflammation, caloric restriction, gut health, liver health, nutritional deficiencies). In some cases, functional practitioners prescribe combination T4/T3 therapy or T3-only therapy to override the rT3 blockade.

The mainstream endocrinology perspective

Mainstream endocrinology generally does not recommend routine Reverse T3 testing. Here's why.

The argument: The clinical utility of rT3 measurement in ambulatory patients (people who are not acutely ill) has not been established in robust clinical trials. There are no validated reference ranges specific to the clinical decisions being proposed. The T3/rT3 ratio has no standardised methodology or established clinical cutoffs.

The concern about treatment changes: Prescribing T3 therapy or combination T4/T3 based on rT3 levels introduces the risk of thyrotoxicosis (excessive thyroid hormone), cardiac arrhythmias, and bone density loss. These are real harms from treatment initiated based on a marker whose clinical significance in this population is unproven.

The alternative explanation for persistent symptoms: Mainstream endocrinology acknowledges that some Hashimoto's patients feel suboptimal despite normalised TSH and T4. The explanations they tend to explore first include coexistent conditions (iron deficiency, vitamin D deficiency, B12 deficiency, depression, sleep disorders, adrenal issues), autoimmune inflammation not captured by TSH/T4 (thyroid antibodies may drive symptoms independently), and individual variation in optimal TSH targets (some patients feel best at the lower end of the TSH range).

The position on testing: Not recommended as routine. If a clinician orders it, it should be interpreted cautiously and should not drive treatment decisions in isolation.

Where the two perspectives overlap, and where they don't

They agree on:

They disagree on:

The physiology behind Reverse T3 is real and well-described. The functional medicine hypothesis, that chronic stress and metabolic dysfunction can shift the T4 conversion balance in a clinically meaningful way, is plausible. But the evidence to support using rT3 to guide treatment decisions in otherwise-well patients is insufficient by the standards of evidence-based medicine. The risk of treatment changes based on a marker with unvalidated clinical cutoffs is real.

If you're considering rT3 testing, the most productive approach is to test it in the context of a thorough thyroid and metabolic assessment, not in isolation, and to interpret it with a clinician who understands both the physiology and the limitations.

Clinical scenarios where Reverse T3 testing may add value

Even within the mainstream critique, there are scenarios where rT3 testing contributes to the clinical picture.

Non-thyroidal illness syndrome (sick euthyroid syndrome). In acutely ill hospitalised patients, rT3 is used to distinguish between true hypothyroidism and the physiological thyroid suppression that occurs during severe illness. This is a well-established use.

Post-severe illness recovery. After major illness, surgery, or prolonged ICU stay, rT3 may remain elevated during recovery, helping explain persistent fatigue and metabolic symptoms that don't correlate with standard thyroid markers.

Severe caloric restriction or eating disorders. Prolonged underfeeding shifts T4 conversion toward rT3. This can produce hypothyroid-like symptoms (fatigue, cold sensitivity, hair loss, cognitive dulling) despite normal TSH. Testing rT3 can confirm the metabolic braking pattern and support the clinical argument for nutritional rehabilitation.

Very low-carb or ketogenic diets. As covered in the keto article, carbohydrate restriction can lower Free T3, and the mechanism involves increased rT3 production. If someone on keto has hypothyroid symptoms with normal TSH and T4, rT3 may help characterise the picture.

Persistent hypothyroid symptoms on levothyroxine with normal standard markers. This is the debated zone. If TSH, Free T4, and Free T3 are all within range, and iron, vitamin D, selenium, B12, and other factors have been addressed, some clinicians (both functional and some open-minded endocrinologists) will test rT3 as an additional data point. The result doesn't dictate treatment, but it adds context to a complex clinical puzzle.

The T3/rT3 ratio: what it claims to show

The T3/rT3 ratio is used primarily in functional medicine as a surrogate marker for "T3 availability" at the cellular level.

The concept: A low ratio (low T3 relative to high rT3) suggests that even if Free T3 in the blood looks normal, the balance at the cellular level may favour rT3 blocking, reducing the amount of active T3 reaching nuclear receptors.

The calculation: Free T3 (pmol/L) divided by Reverse T3 (pmol/L). Some references use different units, which changes the number but not the concept.

The claimed target: A ratio above 0.20 (some sources say above 20 if using ng/dL units for both) is considered adequate. Below this may suggest rT3 dominance.

The mainstream critique: This ratio has no standardised calculation method, no established reference range from large population studies, and no clinical trial evidence linking specific ratio values to specific clinical outcomes or treatment responses. It's a theoretical construct that hasn't been validated in the way that, for example, the TSH-Free T4 relationship has been validated.

If you test the ratio, interpret it as one data point within a thorough assessment, not as a standalone decision-making tool.

How the test works

Standard blood test. Serum Reverse T3 from a venous blood draw.

Fasting: Recommended (8-12 hours) for consistency, particularly if testing alongside other thyroid and metabolic markers.

Timing: Morning, before 10am. Thyroid hormones have mild circadian variation, and morning testing provides the most standardised conditions.

Preparation:

Understanding your result

Reference range (approximate): 0.14-0.54 nmol/L (or 10-24 ng/dL; units vary by lab)

Within range and asymptomatic: No concern. rT3 is at a physiologically normal level.

Within range but symptomatic (with normal TSH, T4, T3): This is the grey zone. A result in the upper half of the reference range alongside hypothyroid symptoms may be interpreted differently by different clinicians. Functional practitioners may view this as a conversion issue. Mainstream endocrinologists may look elsewhere for the symptom explanation.

Elevated (above reference range): Suggests increased T4-to-rT3 conversion. Consider the context: acute illness, caloric restriction, severe stress, very low-carb diet, chronic inflammation, medications (amiodarone, propranolol, corticosteroids can all increase rT3). The cause determines the response.

Low: Uncommon and rarely clinically significant in isolation.

Always interpret alongside Free T3, Free T4, and TSH. Reverse T3 in isolation is meaningless. It only has value as part of the full thyroid picture, and even then, its value is debated.

Who should consider testing

Consider testing if:

You probably don't need rT3 testing if:

Tests to consider through Bloody Good

The Bloody Good Test covers standard thyroid function alongside 100 biomarkers. Pairing with standalone Reverse T3 and selenium tests provides the most thorough thyroid assessment available through the platform.

What to do after testing

If rT3 is normal and standard thyroid markers are optimised: Persistent symptoms likely have a non-thyroid explanation. Revisit iron, B12, vitamin D, sleep quality, stress, and mental health with your GP.

If rT3 is elevated in the context of acute illness or severe caloric restriction: The elevation is physiological. Your body is conserving energy. Address the underlying driver (recover from illness, rehabilitate nutritional intake). rT3 should normalise as the body returns to its baseline state.

If rT3 is elevated on a very low-carb or ketogenic diet: Consider moderating carbohydrate intake. As discussed in the keto article, adding 50-75g of carbs daily often resolves T3 suppression while maintaining metabolic benefits.

If rT3 is elevated alongside persistent hypothyroid symptoms on levothyroxine with all cofactors addressed: This is the scenario where the clinical conversation gets complex. Options include adjusting levothyroxine dose to target a lower TSH within the normal range, addressing chronic stress and inflammation as rT3 drivers, or, with specialist guidance, trialling combination T4/T3 therapy. This last option carries risks and should only be undertaken under specialist supervision.

Do not self-treat based on rT3 alone. The marker is contextual, debated, and lacks the validated clinical framework that guides treatment for TSH and T4. Any management changes should involve your treating clinician, whether that's your GP, endocrinologist, or integrative practitioner.

Explore more biomarkers

Browse the Bloody Good Biomarker Directory